The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Triarii to include Microsoft Azure Sentinel

13 Jan 2021 07:00

RNS Number : 4519L
Falanx Group Limited
13 January 2021
 

 

13 January 2021

 

FALANX GROUP LIMITED

("Falanx", the "Group" or the "Company")

Triarii service expansion to include Microsoft Azure Sentinel

 

Falanx Group Limited (FLX.L), the AIM listed provider of cyber security and strategic intelligence services, is pleased to announce a significant expansion of its cyber security service offerings.

 

In August 2020, Falanx announced the launch of Triarii, its new Managed Detection and Response ("MDR") service. Triarii uses a combination of both best-of-breed and enterprise-class external components whilst remaining technology-agnostic. This gives the Group the advantage of leveraging the most appropriate technologies to deliver the client solution whilst not being restricted to any one vendor. The initial launch of Triarii has been well received and interest continues to grow at pace. Consequently, our sales pipeline of opportunities continues to strengthen both in quantum and quality.

 

In line with this technology-agnostic approach, the Board is now pleased to announce that it has successfully piloted its Triarii service on Microsoft's Azure Sentinel platform. 'Triarii for Sentinel' has been developed in collaboration with a strategic Microsoft partner in the UK public sector - where we have already established interest from within their client base. This service allows Falanx to target a major global market segment - those Managed Service Providers ("MSPs") and their customers that are heavily invested in the Microsoft Azure platform.

 

Rick Flood, MD Falanx Cyber, said "We are delighted with the way our Triarii platform has developed which has created significant interest and opportunities. Through the addition of Triarii for Sentinel we open up an entirely incremental market opportunity.

 

We are witnessing demand for Triarii services in diverse infrastructures, but it is becoming increasingly clear that, for organisations which have opted for the simplicity of consolidating onto Microsoft or have a broad uptake of Microsoft security tools, Triarii for Sentinel is the right service."

 

Falanx Cyber already has several partners who have indicated that both they and their end user customers have a significant focus and investment in Microsoft Azure. The addition of Triarii for Sentinel enables those partners and their customers to fully exploit and benefit from the Microsoft Azure Sentinel capabilities already inbuilt within their infrastructure by adding a proven and trusted Security Operations Centre (SOC) service to manage the output from these tools.

 

Mike Read, Group CEO, commented "The addition of Triarii for Sentinel opens up further opportunity for our Cyber division to service the needs of our customers and partners, and works in conjunction with our current services that include our existing Triarii service,which is already being deployed for the benefit of our SolarWinds customers."

 

For more information on the Triarii Services please visit the following page on our website: https://falanxcyber.com/triarii-sentinel-blog/

 

 

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh

+ 44 (0) 207 710 7600

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

 

+44 (0) 203 934 663

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: https://www.falanx.com/

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFSFMEEFSEDF
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.